These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 38873600)

  • 1. Infection risk in patients with autoimmune cytopenias and immune dysregulation treated with mycophenolate mofetil and sirolimus.
    Comella M; Palmisani E; Mariani M; Dell'Orso G; Licciardello M; Giarratana MC; Arcuri L; Pestarino S; Grossi A; Lanciotti M; Brucci G; Guardo D; Russo G; Dufour C; Fioredda F; Castagnola E; Miano M
    Front Immunol; 2024; 15():1415389. PubMed ID: 38873600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of mycophenolate mofetil for chronic, refractory immune cytopenias in children with autoimmune lymphoproliferative syndrome.
    Rao VK; Dugan F; Dale JK; Davis J; Tretler J; Hurley JK; Fleisher T; Puck J; Straus SE
    Br J Haematol; 2005 May; 129(4):534-8. PubMed ID: 15877736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Addition of sirolimus to standard cyclosporine plus mycophenolate mofetil-based graft-versus-host disease prophylaxis for patients after unrelated non-myeloablative haemopoietic stem cell transplantation: a multicentre, randomised, phase 3 trial.
    Sandmaier BM; Kornblit B; Storer BE; Olesen G; Maris MB; Langston AA; Gutman JA; Petersen SL; Chauncey TR; Bethge WA; Pulsipher MA; Woolfrey AE; Mielcarek M; Martin PJ; Appelbaum FR; Flowers MED; Maloney DG; Storb R
    Lancet Haematol; 2019 Aug; 6(8):e409-e418. PubMed ID: 31248843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival Associated With Sirolimus Plus Tacrolimus Maintenance Without Induction Therapy Compared With Standard Immunosuppression After Lung Transplant.
    Wijesinha M; Hirshon JM; Terrin M; Magder L; Brown C; Stafford K; Iacono A
    JAMA Netw Open; 2019 Aug; 2(8):e1910297. PubMed ID: 31461151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycophenolate mofetil and Sirolimus as second or further line treatment in children with chronic refractory Primitive or Secondary Autoimmune Cytopenias: a single centre experience.
    Miano M; Scalzone M; Perri K; Palmisani E; Caviglia I; Micalizzi C; Svahn J; Calvillo M; Banov L; Terranova P; Lanza T; Dufour C; Fioredda F
    Br J Haematol; 2015 Oct; 171(2):247-253. PubMed ID: 26058843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sirolimus is effective in relapsed/refractory autoimmune cytopenias: results of a prospective multi-institutional trial.
    Bride KL; Vincent T; Smith-Whitley K; Lambert MP; Bleesing JJ; Seif AE; Manno CS; Casper J; Grupp SA; Teachey DT
    Blood; 2016 Jan; 127(1):17-28. PubMed ID: 26504182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal Management of Autoimmune Lymphoproliferative Syndrome in Children.
    George LA; Teachey DT
    Paediatr Drugs; 2016 Aug; 18(4):261-72. PubMed ID: 27139496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term kidney allograft function and survival in prednisone-free regimens: tacrolimus/mycophenolate mofetil versus tacrolimus/sirolimus.
    Chhabra D; Skaro AI; Leventhal JR; Dalal P; Shah G; Wang E; Gallon L
    Clin J Am Soc Nephrol; 2012 Mar; 7(3):504-12. PubMed ID: 22282478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of mycophenolate mofetil for the treatment of autoimmune and chronic idiopathic urticaria: experience in 19 patients.
    Zimmerman AB; Berger EM; Elmariah SB; Soter NA
    J Am Acad Dermatol; 2012 May; 66(5):767-70. PubMed ID: 21783274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcineurin inhibitor-free immunosuppression in pediatric renal transplantation: a viable option?
    Höcker B; Tönshoff B
    Paediatr Drugs; 2011 Feb; 13(1):49-69. PubMed ID: 21162600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sirolimus is effective and safe in childhood relapsed-refractory autoimmune cytopenias: A multicentre study.
    Acar SO; Tahta N; Al IO; Erdem M; Gözmen S; Karapınar TH; Kılınç B; Celkan T; Kirkiz S; Koçak Ü; Ören H; Yıldırım AT; Arslantaş E; Ayhan AC; Oymak Y
    Scand J Immunol; 2024 Aug; 100(2):e13376. PubMed ID: 38741164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sirolimus in association with mycophenolate mofetil induction for the prevention of acute graft rejection in renal allograft recipients.
    Kreis H; Cisterne JM; Land W; Wramner L; Squifflet JP; Abramowicz D; Campistol JM; Morales JM; Grinyo JM; Mourad G; Berthoux FC; Brattström C; Lebranchu Y; Vialtel P
    Transplantation; 2000 Apr; 69(7):1252-60. PubMed ID: 10798738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapamycin improves lymphoproliferative disease in murine autoimmune lymphoproliferative syndrome (ALPS).
    Teachey DT; Obzut DA; Axsom K; Choi JK; Goldsmith KC; Hall J; Hulitt J; Manno CS; Maris JM; Rhodin N; Sullivan KE; Brown VI; Grupp SA
    Blood; 2006 Sep; 108(6):1965-71. PubMed ID: 16757690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycophenolate mofetil for maintenance of remission in steroid-dependent autoimmune pancreatitis.
    Sodikoff JB; Keilin SA; Cai Q; Bharmal SJ; Lewis MM; Raju GS; Willingham FF
    World J Gastroenterol; 2012 May; 18(18):2287-90. PubMed ID: 22611324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: results at 6 months.
    Gonwa T; Mendez R; Yang HC; Weinstein S; Jensik S; Steinberg S;
    Transplantation; 2003 Apr; 75(8):1213-20. PubMed ID: 12717205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sirolimus immunosuppression in pediatric heart transplant recipients: a single-center experience.
    Lobach NE; Pollock-Barziv SM; West LJ; Dipchand AI
    J Heart Lung Transplant; 2005 Feb; 24(2):184-9. PubMed ID: 15701435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-biologic, steroid-sparing therapies for non-infectious intermediate, posterior, and panuveitis in adults.
    Edwards Mayhew RG; Li T; McCann P; Leslie L; Strong Caldwell A; Palestine AG
    Cochrane Database Syst Rev; 2022 Oct; 10(10):CD014831. PubMed ID: 36315029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mycophenolate mofetil: a new immunosuppressive drug in dermatology and its possible uses].
    Geilen CC; Orfanos-Boeckel H; Offermann G; Orfanos CE
    Hautarzt; 2000 Feb; 51(2):63-9. PubMed ID: 10743574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of mycophenolate mofetil in pediatric patients with steroid-dependent nephrotic syndrome.
    Novak I; Frank R; Vento S; Vergara M; Gauthier B; Trachtman H
    Pediatr Nephrol; 2005 Sep; 20(9):1265-8. PubMed ID: 15942779
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.